7540846

Source:http://linkedlifedata.com/resource/pubmed/id/7540846

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001175, umls-concept:C0001857, umls-concept:C0019704, umls-concept:C0030705, umls-concept:C0205179, umls-concept:C0449435, umls-concept:C0683598, umls-concept:C1527148
pubmed:issue	4
pubmed:dateCreated	1995-8-3
pubmed:abstractText	To determine the rate of development of in vitro HIV resistance to (-)2'-deoxy-3'-thiacytidine (3TC) and relate the effect of dose to emergence of resistance.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8710219
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers, http://linkedlifedata.com/resource/pubmed/chemical/HIV Reverse Transcriptase, http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Zalcitabine
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0269-9370
pubmed:author	pubmed-author:CameronJJ, pubmed-author:CammackNN, pubmed-author:CooleyT PTP, pubmed-author:HOSS, pubmed-author:HirstH MHM, pubmed-author:McCaffreyRR, pubmed-author:MontanerJ SJS, pubmed-author:RuedyJJ, pubmed-author:SalomonHH, pubmed-author:WainbergM AMA
pubmed:issnType	Print
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	N
pubmed:pagination	351-7
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:7540846-AIDS-Related Complex, pubmed-meshheading:7540846-Acquired Immunodeficiency Syndrome, pubmed-meshheading:7540846-Adolescent, pubmed-meshheading:7540846-Adult, pubmed-meshheading:7540846-Base Sequence, pubmed-meshheading:7540846-DNA Primers, pubmed-meshheading:7540846-Dose-Response Relationship, Drug, pubmed-meshheading:7540846-Drug Resistance, Microbial, pubmed-meshheading:7540846-Female, pubmed-meshheading:7540846-HIV Reverse Transcriptase, pubmed-meshheading:7540846-HIV-1, pubmed-meshheading:7540846-Humans, pubmed-meshheading:7540846-Lamivudine, pubmed-meshheading:7540846-Male, pubmed-meshheading:7540846-Molecular Sequence Data, pubmed-meshheading:7540846-Mutation, pubmed-meshheading:7540846-Phenotype, pubmed-meshheading:7540846-Proviruses, pubmed-meshheading:7540846-RNA, Viral, pubmed-meshheading:7540846-Reverse Transcriptase Inhibitors, pubmed-meshheading:7540846-Time Factors, pubmed-meshheading:7540846-Zalcitabine
pubmed:year	1995
pubmed:articleTitle	Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complex.
pubmed:affiliation	McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, Canada.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, In Vitro, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II, Clinical Trial, Phase I